P53 mutations and cancer: a tight linkage

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• The TP53 gene is mutated in over 50% of human malignancies, often representing an early event in cancerogenesis.
• While tumor suppressor genes like APC, RB, and VHL are typically inactivated by deletions or truncations, TP53 mutations are frequently missense, producing full-length mutant proteins.
• Mutant p53 proteins can exert functions opposite to wild-type p53, influencing cancer cell metabolism and stress responses.

Purpose of the Study:

• To review the dual role of p53, encompassing its canonical tumor suppressor functions and its newly recognized roles in regulating cell metabolism and oxidative stress response.
• To highlight the distinct mutational patterns of TP53 compared to other tumor suppressor genes and the functional consequences of these mutations.
• To explore the potential of targeting metabolic pathways and antioxidant defenses in p53-mutated cancers.

Main Methods:

• Literature review and synthesis of existing research on p53 function, mutation patterns, and cancer biology.
• Analysis of the differential effects of wild-type versus mutant p53 on cellular processes.
• Exploration of emerging therapeutic strategies based on metabolic vulnerabilities and oxidative stress.

Main Results:

• Mutant p53 proteins can promote cancer cell survival by enhancing glucose and nutrient uptake.
• Mutant p53 contributes to resistance against oxidative stress by mitigating reactive oxygen species (ROS) damage.
• These pro-tumorigenic functions of mutant p53 confer resistance to conventional therapies like ionizing radiation and chemotherapy.

Conclusions:

• Mutant p53 plays a critical role in cancer progression by altering cellular metabolism and stress responses.
• The distinct functional outcomes of mutant p53 present unique therapeutic vulnerabilities.
• Future cancer treatment strategies may involve depleting energy reserves and antioxidants in p53-mutated tumors.